课题基金 / 基金详情

EPIDEMIOLOGY AND PATHOGENESIS OF HEPATITIS B AND C VIRUSES

EPIDEMIOLOGY AND PATHOGENESIS OF HEPATITIS B AND C VIRUSES
乙型和丙型肝炎病毒的流行病学和发病机制
批准号:
2456640
负责人:
E TABOR
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

E TABOR的其他基金

相似基金

相关文献

中文摘要
翻译
丙型肝炎病毒(HCV)在日本非常普遍,这提供了一个
英文摘要
Hepatitis C virus (HCV) is highly prevalent in Japan, which provides an ideal situation for its study. In a cohort study, the interactions of HCV and human T lymphotropic virus type I (HTLV-I) were studied in an area of Japan where both viruses were endemic. Liver cancer death was highly associated with antibody to HCV (anti-HCV). Antibody to HTLV-I (anti-HTLV-I) was somewhat correlated with HCV infection, but provided no added risk for liver cancer. In a related study, a cohort of Japanese Americans in Hawaii was studied; all were descended from persons who had emigrated from Japan before the mid-twentieth century epidemic of HCV in Japan. A strong association between hepatocellular carcinoma (HCC) and hepatitis B virus (HBV) was found in this population, but not between HCC and HCV; this differs from the situation in Japan today, where 80% of HCC patients have HCV infection.Studies were conducted in HCCs from the United States to determine whether DNA mismatch repair defects could play a role. Microsatellite instability was detected in 4 of 10 HCCs. The one HCC patient with multiple p53 exon mutations had microsatellite instability; five patients with multiple p53 intron alterations in the HCC (compared to their own nontumorous livers) had no microsatellite instability. Mismatch repair defects resulting in microsatellite instability might have played a role in hepatocarcinogenesis in four of these patients, but it was unrelated to p53 alterations in three of them.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ROLE OF HEPATITIS B VIRUS IN HEPATOCELLULAR CARCINOMA
HEPATOCELLULAR CARCINOMA IN CHIMPANZEES
TUMOR SUPPRESSOR GENES IN HUMAN HEPATOCELLULAR CARCINOMA
ONCOGENE EXPRESSION IN CELL LINES DERIVED FROM HUMAN HEPATOCELLULAR CARCINOMA
海外基金